Company Overview
About Us
PeLeMed
PeLeMed is dedicated to developing breakthrough drugs based on
platform of new anti cancer drug designing technology.
We are focused on discovery and development of innovative
first-in-class therapeutic candidates through type 1 kinase inhibitor
development platform. We are trying to achieve our ultimate goal
that extend patient survival period and increase life quality.
Using unique drug discovery platform technology we do new drug
developments that is discriminative of other methods, accumulate
plenty of further drug discovery platform technologies and pipelines
and realize globally recognized Bio-Korea via the success of
First-in-Class global innovative new drugs.
Mission
To develop breakthrough new drugs for refractory cancers
To introduce new therapeutics beyond the limitations of currently used
anticancer drugs and improve quality of life of patients who suffered
cancers, neurological diseases, and immune disorders.
Vision
To improve technology through consistent research and development
To become a global leading new drug development company
Organization
